|

Metabolically Armed BCMA CAR-T cells. Clinical Trials

1 actively recruiting trial

Also known as: Meta10-BCMA

Pipeline

Early 1: 1

Top Sponsors

  • Anhui Provincial Hospital1

Indications

  • AL Amyloidosis (AL)1
  • Plasma Cell Leukemia (PCL)1
  • Multiple Myeloma (MM)1
  • Cancer1

Other1 trial

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.